Journal
HAEMOPHILIA
Volume 19, Issue 1, Pages E1-E47Publisher
WILEY
DOI: 10.1111/j.1365-2516.2012.02909.x
Keywords
bleeding disorders; guidelines; hemophilia; management; treatment
Categories
Funding
- Bayer Hemophilia Awards Program
- Baxter
- Novo Nordisk
- Bayer
- CSL Behring
- Wyeth
Ask authors/readers for more resources
Hemophilia is a rare disorder that is complex to diagnose and to manage. These evidence-based guidelines offer practical recommendations on the diagnosis and general management of hemophilia, as well as the management of complications including musculoskeletal issues, inhibitors, and transfusion-transmitted infections. By compiling these guidelines, the World Federation of Hemophilia aims to assist healthcare providers seeking to initiate and/or maintain hemophilia care programs, encourage practice harmonization around the world and, where recommendations lack adequate evidence, stimulate appropriate studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available